NP

Nabanita Paul

Active Director Director DIN 09197175
DIN 09197175 First appointment Jun 2021 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Nabanita Paul

Data last updated:

Nabanita Paul is a Director at Lekarz Biotech Private Limited (since 2021). The company operates in Business Services. Lekarz Biotech Private Limited reported revenue of ₹1.70 Cr (FY 2025).

DIN 09197175
Primary Designation Director
Industry Business Services
First Appointment 08 Jun 2021
Oldest Company Age 5 yrs
Largest company Lekarz Biotech Private Limited · ₹1.70 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lekarz Biotech Private Limited U74999WB2021PTC245674
Director08 Jun 20212021₹1.70 Cr (FY 2025)Active

Board colleagues of Nabanita Paul

NameDINCompanyDesignation
Tapash Pramanick09197174Lekarz Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lekarz Biotech Private Limited
Premium access

Shareholding and investment profile for Nabanita Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nabanita Paul

Nabanita Paul currently holds 1 directorship: Lekarz Biotech Private Limited (Director, since 08 Jun 2021, revenue ₹1.70 Cr (FY 2025)).

Nabanita Paul was first appointed on 08 Jun 2021 as Director at Lekarz Biotech Private Limited.

The current boards of Nabanita Paul's companies include Tapash Pramanick (Lekarz Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available